Disc Medicine, Inc. (IRON) vs MBX Biosciences, Inc. Common Stock (MBX)

A side-by-side comparison of Disc Medicine, Inc. and MBX Biosciences, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Disc Medicine, Inc. logo
IRON
Disc Medicine, Inc.
$2.37B
$61.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.66B
$55.90HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — IRON vs MBX

growth of $100 · dividends reinvested · last 2y
IRON +32.5% (+15.1%/yr)MBX +147.5% (+57.3%/yr)MBX compounded faster over this window
100200300Start $10020252026$133$248
IRON MBX

IRON vs MBX: by the numbers

  • •MBX is the larger company ($2.66B vs $2.37B market cap).

Metrics side by side

Valuation

MetricIRONMBX
P/B ratio3.686.50

Profitability

MetricIRONMBX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-38.17%-25.47%
ROIC-38.21%-28.60%

Growth (annualized)

MetricIRONMBX
Total return CAGR (5Y)10.70%N/A

Go deeper

Full IRON analysisFull MBX analysisInteractive comparison tool

Dig into the metrics

Disc Medicine ROEMBX Biosciences, Inc. Common Stock ROEDisc Medicine operating marginMBX Biosciences, Inc. Common Stock operating marginDisc Medicine revenue growthMBX Biosciences, Inc. Common Stock revenue growthDisc Medicine free cash flowMBX Biosciences, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.